ClinicalTrials HQ

A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to Rituximab

A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to Rituximab

Recruiting · NCT07268521 · Registry updated 2026-08-31
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to RituximabCryoglobulinemic vasculitisRecruitingPhase 22026-08-31NCT07268521

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Assistance Publique - Hôpitaux de Paris985

25 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AP-HMMarseilleFrance13
CH BloisBloisFrance3
CH Le mansLe MansFrance14
CH ValenciennesValenciennesFrance5
CHRU LilleLilleFrance32
CHRU StrasbourgStrasbourgFrance11
CHU BordeauxBordeauxFrance67
CHU CaenCaenFrance48
CHU Clermont-FerrandClermont-FerrandFrance62
CHU DijonDijonFrance37
Chu LyonLyonFrance22
CHU NantesNantesFrance86
CHU NîmesNîmesFrance12
CHU ToulouseToulouseFrance76
CHU ToursToursFrance36
GHSIF MelunMelunFrance1
Hôpital Bichat AP-HPParisFrance1
Hôpital Bicêtre AP-HPLe Kremlin-BicêtreFrance4
Hôpital de La Pitié SalpetrièreParisFrance1
Hôpital FochSuresnesFrance27
Hôpital Henri Mondor AP-HPCréteilFrance4
Hôpital Jean VerdierBondyFrance3
Hôpital LariboisièreParisFrance9
Hôpital Necker AP-HPParisFrance3
Hôpital Saint Louis AP-HPParisFrance7